Tuesday, November 7, 2017
- 9:00AM-11:00AM
-
Abstract Number: 2619
Hemophagocytic Syndrome in Patients from SLE Registry from the Spanish Society of Rheumatology (RELESSER)
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster III: Therapeutics and Clinical Trial Design- 9:00AM-11:00AM
-
Abstract Number: 1976
High and Low Widespread Pain Index Fibromyalgia Patient Groups, Same, or Different?
Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II- 9:00AM-11:00AM
-
Abstract Number: 2385
High Incidence of Hepatitis Related to HBV Reactivation in Rheumatoid Arthritis Patients with Resolved Hepatitis B Infection during Rituximab Treatment
Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2347
High Interferon (IFN) Signatures and Overlapping Clinical Features Characterize Subgroups of Patients with Presumed IFN-Mediated Autoinflammatory Diseases
Pediatric Rheumatology – Pathogenesis and Genetics Poster- 9:00AM-11:00AM
-
Abstract Number: 2509
High Prevalence of Sarcopenia in Axial Spondyloarthropathy Cohort
Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster III: Outcomes, Outcome Measures, and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2366
High Uric Acid As a Risk Factor for Cardiovascular Diseases in Rheumatoid Arthritis Patients
Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2065
Higher Urate Volume Measured By Dual Energy Computed Tomography Is Associated with Unfavourable Cardiovascular Risks in Patients with Gout
Metabolic and Crystal Arthropathies Poster II- 9:00AM-11:00AM
-
Abstract Number: 2709
Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target for Patients with Rheumatoid Arthritis
T Cell Biology and Targets in Autoimmune Disease Poster II- 9:00AM-11:00AM
-
Abstract Number: 2416
Histopathological Change Caused By Biological Treatment in Rheumatoid Arthritis Synovial Tissue
Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 2200
History of Walking for Exercise Is Not Associated with More Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
Osteoarthritis – Clinical Aspects Poster II: Observational and Epidemiological Studies- 9:00AM-11:00AM
-
Abstract Number: 2037
HLA-B27 Testing in Patients >= 45 Years of Age and Subsequent Diagnosis of Late Onset Spondyloarthritis
Measures and Measurement of Healthcare Quality Poster II- 9:00AM-11:00AM
-
Abstract Number: 2158
HLA-DRB1*04:03/*04:06 As the Genetic Susceptibility to Dermatomyositis Positive for Anti-Transcriptional Intermediary Factor 1-γ Antibody in Japanese Population
Muscle Biology, Myositis and Myopathies Poster- 9:00AM-11:00AM
-
Abstract Number: 2643
HO-1 Expression in Monocytes Might Regulate Kidney Damage in Lupus Nephritis Patients
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 2614
Hydroxychloroquine Initiation Dosing Trends and Predictors in Systemic Lupus Erythematosus